We the petitioners ask the United States government to examine and modify the FDA drug approval process. The current process involves a Phase I and II which tests safety and effectiveness. We ask that drugs be released to patients immediately after successfully passing a Phase II trial. Too, we ask that the process be designed such that all drugs successfully passing a Phase II are approved for distribution and that this process be designed such that it takes no longer than 4 calendar years (1,460 days) for approval of new drugs/treatments.
Also, we the petitioners also ask the US government to enter drug reciprocity agreements with other developed countries/jurisdictions, including but not limited to Canada, Europe, Australia & Japan.
We also ask for increased HSV1/2 funding.